首页> 美国卫生研究院文献>Case Reports in Psychiatry >Augmentative Asenapine in a Recurrent Manic Catatonic Patient with Partial Response to Clozapine
【2h】

Augmentative Asenapine in a Recurrent Manic Catatonic Patient with Partial Response to Clozapine

机译:复发性躁郁症患者对氯氮平有部分反应的增强型阿塞那平

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Catatonia is a severe but treatable neuropsychiatric syndrome known since the middle of the nineteenth century. It has been considered for a long time as a subtype of schizophrenia, even though this association occurs only in 10% of cases. In contrast, it is frequently observed in bipolar patients. First-line treatment consists of benzodiazepines, while in case of resistance electroconvulsive therapy (ECT) and clozapine have shown positive results. In addition, recent studies reported the efficacy of some atypical antipsychotics. The present case shows the clinical response to augmentative asenapine in a catatonic manic patient with a partial response to clozapine.
机译:卡塔龙尼亚是一种严重的但可治疗的神经精神综合症,自19世纪中叶以来就广为人知。尽管这种关联仅发生在10%的病例中,但长期以来一直被认为是精神分裂症的一种亚型。相反,在双相型患者中经常观察到这种情况。一线治疗包括苯二氮卓类药物,而在抗惊厥性电痉挛治疗(ECT)和氯氮平中显示出积极效果。此外,最近的研究报道了一些非典型抗精神病药的功效。本例显示了在紧张性躁狂患者中对增强型阿塞那平的临床反应以及对氯氮平的部分反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号